MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Moleculin Biotech, Inc. (MBRX)

Moleculin Biotech, Inc. (MBRX)

|||

Balance Sheets Overview

Current Ratio
93.66%
Quick Ratio
93.66%
Cash Ratio
77.98%
Debt to Asset Ratio
45.05%
Unit: Thousand (K) dollars
Assets Breakdown
    • Intangible assets
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
7,262
10,317
8,878
6,703
Prepaid expenses and other current assets
1,461
644
808
1,182
Total current assets
8,723
10,961
9,686
7,885
Intangible assets
11,148
11,148
11,148
11,148
Other non-current assets
900
900
900
900
Operating lease right-of-use asset
254
284
314
343
Furniture and equipment, net
62
70
78
77
Total assets
21,087
23,363
22,126
20,353
Accounts payable
4,337
4,574
3,508
2,116
Accrued expenses and other current liabilities
4,976
3,388
3,346
3,566
Total current liabilities
9,313
7,962
6,854
5,682
Operating lease liability - long-term, net of current portion
147
185
222
258
Warrant liability
40
33
44
41,333
Total liabilities
9,500
8,180
7,120
47,273
Common stock, 0.001 par value 500,000,000 shares authorized 7,100,000 and 3,199,228 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
7
5
3
49
Additional paid-in capital
238,128
234,079
220,997
194,631
Accumulated other comprehensive loss
-
-
-
-44
Accumulated other comprehensive income (loss)
-64
-52
10
-
Accumulated deficit
-226,484
-218,849
-206,004
-221,556
Total stockholders equity
11,587
15,183
15,006
-26,920
Total liabilities and stockholders equity
21,087
23,363
22,126
20,353
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$7,262K (-3.90%↓ Y/Y)Prepaid expenses andother current assets$1,461K (-3.82%↓ Y/Y)Intangible assets$11,148K (0.00%↑ Y/Y)Total current assets$8,723K (-3.89%↓ Y/Y)Other non-currentassets$900K (0.00%↑ Y/Y)Operating leaseright-of-use asset$254K (-31.35%↓ Y/Y)Furniture and equipment,net$62K (-37.37%↓ Y/Y)Total assets$21,087K (-2.34%↓ Y/Y)Total liabilities andstockholders equity$21,087K (-2.34%↓ Y/Y)Total stockholdersequity$11,587K (261.72%↑ Y/Y)Total liabilities$9,500K (-66.97%↓ Y/Y)Accumulated deficit-$226,484K (-35.26%↓ Y/Y)Accumulated othercomprehensive income (loss)-$64K Additional paid-in capital$238,128K (48.56%↑ Y/Y)Total currentliabilities$9,313K (17.69%↑ Y/Y)Operating lease liability- long-term, net...$147K (-49.66%↓ Y/Y)Warrant liability$40K (-99.81%↓ Y/Y)Common stock, 0.001 parvalue 500,000,000...$7K (-76.67%↓ Y/Y)Accrued expenses andother current...$4,976K (18.70%↑ Y/Y)Accounts payable$4,337K (16.55%↑ Y/Y)